Investing.com - Enfusion (NYSE: ENFN) reported third quarter EPS of $0.05, worse than the analyst estimate of $0.06. Revenue for the quarter came in at $51.17M versus the consensus estimate of $52.17M.
Enfusion's stock price closed at $9.05. It is up 14.70% in the last 3 months and up 5.23% in the last 12 months.
Enfusion saw 1 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Enfusion's stock price’s past reactions to earnings here.
According to InvestingPro, Enfusion's Financial Health score is "good performance".
Check out Enfusion's recent earnings performance, and Enfusion's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar